You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:16:13 UTC
Last Updated2019-10-01 21:37:11 UTC
CypComp IDCC00048
Compound Information
NameBupivacaine
Structure ImageLebvlxferqhonn inizcteosa n
InChIKeyLEBVLXFERQHONN-INIZCTEOSA-N
PubChem ID92253
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
Non-ReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantReactantReactantNon-ReactantReactant
References
  1. Gantenbein M, Attolini L, Bruguerolle B, Villard PH, Puyoou F, Durand A, Lacarelle B, Hardwigsen J, Le-Treut YP: Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab Dispos. 2000 Apr;28(4):383-5. [PubMed:10725304 ]
Download FileCC00048.sdf